ISE assembly, sample assembly, and punip/electronic assembly. After dilution with a buffer in the sample assembly, the sample is aspirated through the ISE assembly for analysis simultaneously with a counterfiow reference reagent solution. The pump/electronic assembly controls the movement of sample and reagent through the ISE assembly and the electronic signals between the assemblies. The RA-1000 is calibrated with a two-point calibration, i.e., with high-and low-concentration calibrators.
At the beginning of each worklist (run) and approximately every 8 mm during the course of analysis, the ISE automatically analyzes a wash solution as a one-point calibration, to adjust the baseline if necessary and to check for drift, and the voltage range.
To measure chloride in the RA-b000, a colorimetric method with mercuric thiocyanate (4) is used; in the ASTRA-8 a chloride electrode (coulometric-amperometric titration) is used. In the HA-bOO chloride method-an equilibrium, bichromatic assay-the assay mixture is measured at 500 nm after 3 mm of reaction; bichromatic blanking is made with measurements at 600 nm.
Calibration:
The HA-bOO ISE was calibrated every 4 h with two solutions: a "high" calibrator (containing the stability of RA-b000 performance by measuring the control or calibrator material both more frequently than and also beyond the time recommended by the manufacturer for a new calibration. Precision. Precision was assessed according to the National Committee for Clinical Laboratory Standards (NCCLS) protocol EP5-P by assaying quality-control materials and plasma pools in duplicate in the morning and in the afternoon for 11 days. The total SD and CV were calculated from all results n each of three levels of quality-control materials.
Linearity.
Technicon TQC Alert#{174} 1 and 2 lyophilized
serum-based quality-control materials were reconstituted in various amounts of de-ionized water to prepare each in a high and a low concentration. Equal volumes of these two preparations were mixed to produce a middle concentration; we also prepared "mid-high" and "mid-low" concentrations. Nat, K, and Cl measured in these preparations were compared with the calculated expected values, and linearity was assessed by linear regression analysis. The TQC Alert control materials are not recommended for routine use as an HA-bOO ISE control because they contain enough salicylate to interfere with CO2 measurement.
Thus, to assess the linear range for C02, we used a serum-based quality-control material reconstituted with solutions of sodium bicarbonate in various concentrations.
Method comparison.
Using both instruments, we analyzed more than 100 patients' plasma samples according to the NCCLS protocol PSEP-4. Each specimen was analyzed in duplicate for Na, K, and C1 and in singlet for CO2 on both instruments within a 2-h time. No more than 20 specimens were analyzed on a single day. Outliers were detected and eliminated, when present, from regression analysis according to the NCCLS protocol.
Carryover.
Technicon TQC Alert control was reconstituted in de-ionized water and salt solution to serve as the "low" pool and the "high" pool, respectively. The salt solutions for the measurements of Na, K, C1, and CO2 were NaCl 1500 mmol/L, KC1 60 mmol/L, NaCl 1000 mmol/L, and NaHCO3 300 mmol/L, respectively. Thus, the "high" pool was a serum-based material with 10 times the physiological concentrations of Na, K, C1, and CO2. Four samples of the "high" pool were followed by four samples from the "low" pool in the assay. The difference in concentration between the first "low" pool sample and the average of the last two "low" pool samples was divided by the concentration of the "high" pool as an estimate of the amount of carryover.
Interferences.
Technicon TQC Alert control was reconstituted in solutions containing high concentrations of lithium, calcium, ammonia, magnesium, and bromide. The Na and K results for these preparations were compared with those for the same control material reconstituted in de-ionized water. To study salicylate interference with the CO2 electrode, we used patients' specimens known to contain high concentrations of the drug; we also added salicylate to drugfree pooled plasma. Concentrations of ammonia and saucylate were determined with an aca discrete analyzer (DuPont Instruments, Wilmington, DE 19898). To study interference from hemolysis and icterus, we determined the analytical recoveries of Na, K, Cl-, and CO2 after adding standard solutions of NaC1, KC1, or NaHCO3 to icteric or hemolyzed plasma pools. To evaluate the effect of lipemia, we analyzed lipemic plasma or serum samples before and after ultracentrifugation.
Results

For various concentrations
of quality-control materials, the total CVs (11 days, 44 analyses) were no more than 1.3% for Na, K, and C1, and no more than 3.8% for CO2 (Table  1) . The RA-1000 responses varied linearly with electrolyte concentration ( Table 2) .
Correlation of results for plasma samples as measured with both the RA-b000 and the ASTRA-8 is shown in Figures 1-4 
Values -0.001
Moderate lipemia (triglyceride of 7 g/L and an absorbance of 0.5 at 600 nm and 1-cm light path after 10-fold dilution in water) produced a positive bias of 5 to 7 mmol/L in Cl measurement but had no effect on Na', K, or CO2. Severe lipemia produced a negative bias in Na values and a positive bias in CO2 values. For example, a grossly lipemic specimen (triglyceride of 33 g/L) caused a negative bias of 5 mmolfL for Na with the HA-bOO and 8 mmol/L for Na with the ASTRA-8. The HA-bOO detected all positive interference with CO2 and Cl-caused by severe lipemia and printed an error code next to the result. Severe lipemia is detected by monitoring the change in absorbance at 600 nm before and after sample addition in the C1 assay, and by the electrode response curve in the CO2 assay. Serum blanking is not programmable with the Cl assay, which is a bichromatic method.
Actual analysis time for measurements
of Na, K, Cl-, and CO2 in 30 specimens was 25 mm with the RA-1000, 31 miii with the ASTRA-8.
Discussion
We have evaluated measurement of Na, K, C1, and CO2 in the HA-bOO, with particular attention to potential technical problems that may affect results. The precision study conducted according to NCCLS protocol demonstrated satisfactory performances for all four tests. The CVs were comparable to those exhibited by the ASTRA-8 system in our laboratory.
Acceptable performance in linearity was confirmed with regression analysis of our data for the four assays. The linear ranges are sufficient for clinical need.
For method comparison, we compared many HA-bOO results for patients' specimens with those obtained with the ASTRA-8, finding a good correlation.
Although the manufacturer recommends calibrating the ISE every 4 h, we found that a calibration can hold up to 8 h for Na, K, and CO2 measurements. For chloride, we found that the calibration curve was stable for at least four weeks. Compared with the required calibration of the ASTRA, every 75 mm, the much less frequent calibrations needed with the HA-bOO save reagent, calibrator, and qualitycontrol materials as well as instrument time. This feature becomes more important when rapid turnaround of results is needed on stat requests and a calibration cycle (e.g., approximately 7 miii with the ASTRA-8 for the four analyte8) can delay the process.
We found that the HA-b 000 had higher throughput than the ASTRA-8 in measuring all four analytes. If Cl-is not requested, the RA-1000 would be even faster, because it takes as much time to analyze for Cl-as to do all the three ISE tests, i.e., Na, K, and CO2. Using a serum-based material with Nat, K, C1, and CO2 added to 10-fold the physiological concentrations, we detected negligible carryover with the ISE tests and concluded that the system is satisfactory for clinical use. For Cl-, which is a non-ISE assay in which "random access fluid" is used in all sampling probes to encapsulate the samples and reagents, no carryover could be detected.
In the interference study, high concentrations of cations such as Li, Ca2, and Mg did not interfere with measurement of Na and K. In patients with hepatic coma (5) or severe Reye's syndrome (6), serum ammonia values as high as 0.6 mmol/L have been reported. We showed that 2.0 mmol of ammonia per liter did not interfere with the HA-1000 ISE for Na, K, or CO2 measurements.
Although bromide has been replaced by barbiturates nowadays in medical treatment, the former reportedly produces a positive interference with ISE and colorimetric thiocyanate methods for Cl determination (7). We confinned this in the HA-bOO system, in which the thiocyanate method is used. Thus, if a substantially supranormal chloride concentration is found in a specimen, it should be confirmed coulometrically;
if that method yields a significantly lower result, interference by bromide should be suspected. Nevertheless, bromide should seldom be a problem, because it is rarely used as a therapeutic agent today.
Because salicylate reportedly produces a positive interference with the carbonate ionophore method for CO2 measurement on the Kodak Ektachem 400#{174} system (8), we decided to investigate its effect on the HA-bOO ISE. Indeed, we detected a positive interference of 4 to 8 minol/L with CO2 measurement in patients' sera that contained b50 to 300 mg (1.08-2.17 mmol) of salicylate per liter. This was caused by an interaction of salicylate with carbonate ionophore to simulate high CO2 readings and shorten electrode response time. Since then the manufacturer has revised the software program on the HA-bOO so that it can detect any salicylate interference exceeding approximately 4 mmol/L, and an error code is printed ("flagged") next to the CO2 result. The revised software can distinguish an abnormal curve of CO2 electrode response that does not plateau within the analysis time (5.5 s), as in the case of salicylate interference. We have confirmed the ability of the new software (RA-b000 Program Disk, version 2.3) to detect the salicylate interference. We (and the manufacturer) recommend that the four samples following a "flagged" sample be reanalyzed to veri1' proper CO2 values. If the repeated results of the four specimens differ substantially from their original values, the rest of the samples in the original run, excluding the "flagged" specimen, should be repeated. The "flagged" specimen should be analyzed by an alternative method. In our evaluation, exposure to salicylate did not appear to shorten the useful life of the CO2 membrane.
Thus, unlike the Ektachem 400, the HA-b000 is programmed to limit undetected interference of salicylate, if present, to an amount corresponding to no more than 4 mmol of CO2 per liter. In our method-comparison study, we randomly selected 441 patients' specimens; none of the CO2 results were "flagged" with the error code, and no apparent positive bias was found when the results were compared with those of the ASTRA-8. We did our interference study by screening many specimens from arthritis patients (who may be taking a high dose of aspirin) and found a few specimens with salicylate concentrations in the range 150-300 mgIL. The dosage of salicylate resulting in concentrations of 150-300 mg/L in plasma is generally 3-6 g per day (e.g., 15 to 30 tablets of Excedrin, each containing 0.2 g of salicylate) (9). In our hospital, we estimate that less than 0.1% of the specimens we receive have salicylate concentrations >150 mgIL. Nevertheless, many commercial qualitycontrol products contain salicylate, so it is essential that laboratories confirm the absence of salicylate in their controls before using them in the HA-bOO ISE.
Moderate icterus and hemolysis did not significantly interfere. Although the RA-b000 ISE is an indirect potentiometric method, only severe lipemia caused a significant negative bias on Na results. The negative interference in the HA-bOO was smaller in magnitude than that in the ASTRA-8 because the effect of severe lipemia is diminished when a lower dilution ratio is used: the RA-1000 dilutes the specimen with 14 volumes of buffer, the ASTRA-8 with 26 volumes. Nevertheless, all severely lipemic specimens should be analyzed by direct ISE or ultracentrifuged before analysis by indirect ISE.
In summary, the interferences revealed by our study on the RA-1000 were either insignificant or involved rarely encountered specimens with easily detectable and correctable types of interferences. Thus, we believe that the HA-1000, like the ASTRA-8 and Ektachem 400, is acceptable for clinical use in measuring Nat, K, Cl, and CO2. We found the HA-bOO to be precise, easy to use, and to require minimal maintenance.
The system also provides high throughput and random-access capability.
